This inventor holds 1 USPTO granted patent. Top assignees: Administrative Center of New Drug Research, the State Pharmaceutical, China Pharmaceutical University. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovations of Dezai Dai
Introduction
Dezai Dai is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Dezai Dai holds a patent for a tetrahydroprotoberberine quaternary ammonium compound. This compound is represented by a specific formula and is designed to suppress arrhythmia and ventricular fibrillation. It also offers protection against myocardial ischemia and can be conveniently administered orally. This patent highlights his commitment to advancing medical science through innovative chemical solutions.
Career Highlights
Throughout his career, Dezai Dai has worked with esteemed institutions such as China Pharmaceutical University and the Administrative Center of New Drug Research at the State Pharmaceutical. His experience in these organizations has allowed him to contribute to significant advancements in drug development and research.
Collaborations
Dezai Dai has collaborated with notable colleagues, including Wenlong Huang and Can Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Dezai Dai's contributions to the field of pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his dedication to improving health outcomes through scientific advancements. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile